This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Challenges and solutions

Over the years to come, Life Sciences companies will be facing sweeping demographic shifts, increasing globalization, mounting R&D costs, the rise of emerging markets and accelerating convergence between industry sectors. These challenges will bring both opportunities and risks (click on the challenges for more information):

Life Sciences & Health Care - Challenges and Solutions diagram Manage Market Potential Optimize R&D Manage Regulatory Environment Partnerships Build Well-governed Organisation & Manage Talent Optimize Cost Efficiency IT Business Alignment

Featured topics

  • Managing market potential
    The industry is moving away from blockbusters, and is increasingly focusing on new niche products. It is becoming crucial for companies to think carefully about their current portfolio and optimize its management.
  • Optimize R&D
    Nowadays R&D organisations are under huge pressure as their productivity remains unsatisfactory despite the massive increases in R&D spend and significant efforts on improving operational excellence.
  • Manage regulatory environment
  • Partnerships
    Partnerships are currently seen by key industry leaders as an important element in the development of a new successful Life Sciences business model.
  • Build well-governed organisation & manage talent
    With more outsourcing, more stakeholders involved, more regulatory requirements, more financial investments, .., the overall complexity of a life sciences company is definitely increasing significantly.
  • Optimize cost efficiency
    The pressure on costs will induce the implementation of a new organizational model characterized by more analytical and value adding activities and a higher level of shared processes.
  • IT business alignment
    For a long time companies have been dealing with a considerable amount of market data on a regular basis, often employing resources in a method that is simultaneously inefficient, costly and prone to generate errors.

More Learn more

  • Life Sciences & Health Care newsletter

Related link

  • Related links
    Deloitte global in life sciences and health care

Email Us Facebook Twitter Youtube LinkedIn Corporate LinkedIn Alumni Flickr

Material on this website is © 2013 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

Get connected

 

More on Deloitte
Learn about our site